Related references
Note: Only part of the references are listed.Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt
Bruno Silvester Lopes et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA)
Suleiman Al-Obeid et al.
JOURNAL OF CHEMOTHERAPY (2015)
Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia
M. Aly et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Pan-resistant Acinetobacter infection in neonates in Karachi, Pakistan
Ali Faisal Saleem et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2010)
Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine
Abdel Moati Kh. Al Jarousha et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
An increasing threat in hospitals:: multidrug-resistant Acinetobacter baumannii
Lenie Dijkshoorn et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit
Lisa S. Young et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Axel Kramer et al.
BMC INFECTIOUS DISEASES (2006)
Treatment of multidrug resistant Acinetobacter
CK Murray et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2005)
Clinical impact and pathogenicity of Acinetobacter
ML Joly-Guillou
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Multidrug-resistant Acinetobacter baumannii
A Abbo et al.
EMERGING INFECTIOUS DISEASES (2005)
Share Paper
